April 21, 2011

Federal Limited Submission Funding Opportunities

General guidelines
All applicants for federal limited submission funding opportunities should notify the Office of Research of their intention to apply. An internal proposal should be submitted; if necessary a faculty review committee will select the institutional applicant(s). Unless otherwise specified, internal proposals should include the following:

 Faculty PI/PD(s)
 Tentative title of the intended proposal
 Names of other key faculty, departments expected to participate
 A brief (one page maximum) summary of the scope and content of the program.

Additional information may be requested.

Questions? Contact Susan Meyn in the Office of Research for more information, or to submit an internal proposal.


Recent Funding Opportunity Announcements
Clinical Hematology and Transfusion Medicine Research Career Development Program (K12)
RFA-HL-12-005: http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-12-005.html

Vanderbilt is limited to a single application to this program.

Internal Proposal Deadline: May 5
Application Due Date: June 20

The purpose of this program is to develop and evaluate multidisciplinary career development programs in non-malignant hematology and transfusion medicine that will equip new investigators with the knowledge and skills to address complex problems in blood diseases and transfusion medicine.

Through this program, the NHLBI will support the early career development of clinical researchers who are expected to become independent investigators and assume academic leadership roles in non-malignant clinical hematology and transfusion medicine. To accomplish this, NHLBI invites institutions with established clinical research infrastructures and expertise in non-malignant clinical hematology and transfusion medicine to submit applications to establish Clinical Hematology and Transfusion Medicine Research Career Development Programs.

Programs supported under this FOA should provide comprehensive, multidisciplinary training in research designs and methodologies, standard and potentially future or innovative approaches to the clinical management of patients with non-malignant hematologic diseases as well as transfusion practices for multiple patient populations and research opportunities in these clinical settings. Programs should include a core curriculum, didactics and a short-term research project for each Scholar.